CVS, Omnicare reach $440M settlement with DoJ, Modern Healthcare reports

Long-term care pharmacy services provider Omnicare has agreed to pay $440 million to settle False Claims Act allegations, Modern Healthcare's Noah Tong reports. Of note, back in May of this year, Omnicare, a subsidiary of CVS Health, announced that following a comprehensive sale process, the U.S. Bankruptcy Court for the Northern District of Texas has approved the sale of the company's business to GenieRx Holdings, a joint partnership between private investment firm Milrose Capital and health-care investment and management firm Integro Asset Management, which does business as Integro Healthcare Services. Reference Link